Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US62855J1043
Ticker MYGN
Company MYRIAD GENETICS
Currency $
Price
Aware Investor Index (AII) 0.1202
Recommendation HOLD
P/E 33.39
ROE 13.25 %
Capitalization 3,310,852,000 $
Dividend Yield 0.00 %
P/S 4.39
AII Position 465
P/E Position 447
ROE Position 309
Capitalization Position 647
Dividend Yield Position 629
Sales 753,800,000 $
10-Year Average Earnings 99,152,600 $
Shares Outstanding 72,400,000
Equity 748,100,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
MYRIAD GENETICS Investor Relations Web Site http://investor.myriad.com







Sales:

YEAR MONTH AMOUNT
2016 6 753,800,000.00 $
2015 6 723,100,000.00 $
2014 6 778,216,000.00 $
2013 6 613,165,000.00 $

Earnings:

YEAR MONTH AMOUNT
2016 6 125,300,000.00 $
2015 6 80,200,000.00 $
2014 6 176,225,000.00 $
2013 6 147,139,000.00 $
2012 6 112,151,000.00 $
2011 6 100,710,000.00 $
2010 6 152,303,000.00 $
2009 6 84,615,000.00 $
2008 6 47,845,000.00 $
2007 6 -34,962,000.00 $

Equity:

YEAR MONTH AMOUNT
2016 6 748,100,000.00 $
2015 6 662,100,000.00 $
2014 6 718,998,000.00 $
2013 6 728,594,000.00 $
2012 6 635,660,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2016 6 72,400,000
2015 6 74,500,000
2014 6 78,182,000
2013 6 83,327,000
2012 6 86,465,000

 












Bloomberg News for MYRIAD GENETICS:

Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
620 87,737 MYRX MYREXIS INC 171,102 212,920 27,673 MYGN MYRIAD GENETICS 2,889,711 2,829,144 719,834 NABI NABI BIOPHARMA...
Jun 22, 2007
Stocks: Eleven Cash-Flow Champs
14.83 Myriad Genetics (MYGN) 36.64 ...
Nov 17, 2003
Raising Forecast for Children's Place
estimate: .55 Rationale: See stronger operating income Company: Myriad Genetics (MYGN ) Year ending: Jun-2004 Prior estimate: -1.11 New estimate: -1.34 ...
May 22, 2001
Reaping the Bush Dividend
one called Human Genome Sciences (HGSI ), and there's another one called Myriad Genetics (MYGN ). I'm not necessarily recommending those firms as the best ones to look at, but I'm saying...
Dec 30, 2005
S&P's Top-Shelf Selections
of $135 billion for Procter & Gamble (PG ) to a low of $700 million for Myriad Genetics (MYGN ). By contrast, the median market capitalization of the S&P 500 index is about $10.3 billion...
Feb 7, 2005
Online Extra: Healthy Investment?
5.46 Prostate Cancer VIOLTS (FTPCSX) Myriad Genetics (MYGN) 10.07 Medarex (MEDX) ...
Aug 26, 2003
CS First Boston Lowers Myriad Genetics to 'Neutral'
Credit Suisse First Boston downgraded Myriad Genetics (MYGN ) to neutral from outperform. Analyst Mark Augustine says...
Dec 14, 2006
S&P Ups Oracle to Strong Buy
reflecting a multiple reduction due to the aforementioned sales risks. Myriad Genetics (MYGN): Cuts to 3 STARS (hold) from 4 STARS (buy) Analyst: Paul Starsia Our downgrade comes...
Aug 9, 2011
U.S. Companies Reporting Earnings on Aug. 9
99.5 0.08 NM Jun MRVC# MRV COMM 0.01 na na 0.01 0.0 Jun MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 Jun TICKER ...
Aug 9, 2011
U.S. Companies Reporting Positive EPS Surprises, Aug. 9
2.84 10.66 HPT HOSPITALITY PROP 0.89 0.81 9.9 0.86 3.5 2.45 12.86 MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 1.07 5.97 TNGN# TENGION INC...


Google News for MYRIAD GENETICS:

StreetInsider.com - 4 days ago
Myriad Genetics (MYGN) to Present Seven Studies at ASCO
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will present ...
The Cerbat Gem
Myriad Genetics Inc (NASDAQ:MYGN) Institutional Investor Positioning
Myriad Genetics Inc (NASDAQ:MYGN) institutional sentiment increased to 1.1 in Q4 2016. Its up 0.13, from 0.97 in 2016Q3. The ratio increased ...
BangaloreWeekly
Myriad Genetics (MYGN) Q3 2017 Results - Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the Myriad Genetics Third Quarter 2017 Financial Earnings Conference Call.
UtahHerald.com
Can Myriad Genetics (MYGN) Spring a Surprise in Q3 Earnings?
Last quarter, the company posted a positive earnings surprise of 8.33%. However, Myriad Genetics missed the Zacks Consensus Estimate in ...
Finance News Daily - 12 hours ago
Myriad Genetics (MYGN) Says Data Shows Prolaris Test Accurately ...
Myriad Genetics (MYGN) Says Data Shows Prolaris Test Accurately Predicts 10-Year Risk of Metastases in Men Treated for Prostate Cancer.
Sports Perspectives
Myriad Genetics (MYGN), Clovis (CLVS) Enter Pact for Use of ...
Myriad Genetics (MYGN), Clovis (CLVS) Enter Pact for Use of BRACAnalysis CDx Test to Identify Patients with Germline BRCA Mutations for ...
BBNS
Myriad Genetics (MYGN) Getting Positive Media Coverage, Analysis ...
Myriad Genetics logo Media coverage about Myriad Genetics (NASDAQ:MYGN) has been trending positive on Friday, according to Alpha One ...
Chaffey Breeze
Taking a Fresh Look at Myriad Genetics, Inc. (MYGN)
Myriad Genetics, Inc. (MYGN) is an interesting player in the Services space, with a focus on Research Services. The stock has been active on ...
Seeking Alpha - 2 May 2017
Today's Brokerage Rating: Callon Petroleum Company (CPE ...
Myriad Genetics, Inc. (NASDAQ:MYGN) ended its day at $18.33 with the rising stream of 3.27% and its total traded volume was 1.3 million ...
Yahoo Finance
Here's the Latest Chart Setup For Myriad Genetics, Inc. (MYGN)
Myriad Genetics, Inc. (MYGN) is looking very interesting as a trading opportunity right now. The technical setup offers the best window into what ...


Back